Federation Des Caisses Desjardins Du Quebec Kempharm, Inc Transaction History
Federation Des Caisses Desjardins Du Quebec
- $23.7 Billion
- Q3 2025
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Kempharm, Inc stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 50 shares of KMPH stock, worth $247. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50Holding current value
$247% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding KMPH
# of Institutions
178Shares Held
36.6MCall Options Held
4.73MPut Options Held
1.25M-
Woodline Partners LP San Francisco, CA3.48MShares$17.2 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.08MShares$15.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.7MShares$13.3 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.23MShares$11 Million0.02% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT1.97MShares$9.74 Million0.39% of portfolio
About KEMPHARM, INC
- Ticker KMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,493,600
- Market Cap $170M
- Description
- KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...